Many countries use external reference pricing to help determine drug prices. However, external reference pricing has received little attention in the US—perhaps because the US is often the first ...
Congress and President Joe Biden have highlighted large numbers of drug patents that brand-name manufacturers receive on their products as contributing to US patients paying far more for brand-name ...
A new study found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario.
An online subscription to ADA/PDR Dental Therapeutics also provides access to PDS3D, a digital reference product that pairs the largest human drug label database available with an intuitive search ...
The Trump administration has proposed using international pricing of drugs to establish ceilings on what Medicare will pay for therapies administered by physicians in their offices or in hospital ...
The US Food and Drug Administration (FDA) is recommending drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs they reference.